In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
Objective: Diabetes mellitus (DM) is a risk factor for developing in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). This study aimed to examine the presentation and outcomes of drug-eluting stent (DES) ISR in diabetics. Methods: This retrospective study included consecuti...
Main Authors: | Ganesh Paramasivam, Tom Devasia, Ashwal Jayaram, Abdul Razak U.K, M. Sudhakar Rao, Rajesh Vijayvergiya, Krishnananda Nayak |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-12-01
|
Series: | Anatolian Journal of Cardiology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-72916 |
Similar Items
-
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
by: Ganesh Paramasivam, et al.
Published: (2019-11-01) -
Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment
by: Shivanand Patil, et al.
Published: (2020-01-01) -
Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01) -
Usefulness of Drug Eluting Stent in Percutaneous Coronary Intervention—A Single Center Experience in Taiwan
by: Juey-Jen Hwang, et al.
Published: (2007-08-01) -
Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)